Since the report of hypotensive effect without central depression of 10-methoxy deserpidine (1), several investigators have studied the mode of its action. Mir and Lewis (2) have demonstrated the gradually developing fall of blood pressure following 10-methoxydeserpidine in cats, rabbits and rats. However, unlike reserpine, 10-methoxydeserpidine does not produce significant depletion of brain and heart nor adrenaline in mice (3). Recently, Higuchi et al. (4) and Toda et al. (5) in this laboratory have reported that the intravenous or intracarotid injection of 5 to 10 mg/kg of 10 -methoxydeserpidine in rabbits produces considerable depletion of catecholamines in the brain, heart and adrenal glands. The latter authors (5) have further shown that the intravenous injection of 10 mg/kg of 10-methoxydeserpidine to rabbits results in a sustained rise of the skin temperature of the ear without modifying the rectal tempe rature, and that 1 mg/kg of reserpine produces a similar but longer-lasting rise of the ear skin temperature with a significant fall of the rectal one. They suggested that the skin temperature rise might be due to an increased blood flow in the ear. The earlier observation by Guthrie (6) that the inhalation of amyl nitrite, a potent coronary vasodilator, in man produced a flushing of the skin with a temperature rise and a blood flow increase in the neck and face indicates a resemblance of the effects of amyl nitrite to those of 10-methoxydeserpidine and reserpine.
fixed on the board in a supine position and placed in the electrically shielded room at about 24°C. The sites of leading electrode in the medial part of the right fore and left hind limbs were shaved. The steel electrodes were inserted subcutaneously and fixed by plaster. The ECG (lead II) was registered on the paper by means of the universal recorder (San'ei Sokki, Type 204). External stimuli such as sound , light and touch were made as minimum as possible. Usually about two hours were required before the animal fell into a full calmness to permit stable recording of the ECG .
The drugs used were vasopressin (Pitressin, Parke-Davis), l0-methoxydeserpidine (Decaserpine, Roussel), atropine sulfate and 2,6-bis-(diethylamino)-4,8-dipiperidino pyrimido (5,4-d)-pyrimidine (Persantin, Boehringer-Sohn). 10-Methoxydeserpidine 500 mg was dissolved in 5 ml of propylene glycol with 0.2 ml of glacial acetic acid and employed as a stock solution. All drugs were injected into the marginal ear vein . RESULTS 
I. Effects of vasopressin on ECG
The intravenous injection of 1.0 U/kg of vasopressin produced a variety of ECG changes at various latencies : sinus bradycardia, sinus arrhythmia , prolongation and shortening of PQ interval, ventricular extrasystole, increase in height of T wave , eleva tion or depression of ST level and flattening or reversal of T wave (Table 1) . How ever, these ECG changes were subjected to individual variations in latency , duration and intensity. TABLE 1 . The ECG changes following the intravenous injection of vasopressin (1.0 U/kg) in normal rabbits.
* The reduction of heart rate to less than 50% of initial rate at 2 minut es after the administration of vasopressin is designated as sinus bradycardia .
Rhythm
The first injection of 1.0 U/kg of vasopressin . produced arrhythmia in 21 of 24 rabbits tested. Most. of them °wee of sinus origin, as shown in Fig . 1 . In 6 rabbits, other types of arrhythmia such as the bigeminal or, trigeminal rhythm , the irregular manifestation of ventricular extrasystole and the ventricular rhythm were also . observed. These arrhythmias usually (81% of observations) began . to appear 10 to 30. seconds. after injection of vasopressin and lasted for period of 237.4±83.1 seconds (mean±S.E.). Fig. 2 , after, the trigeminal 30 seconds after, and the marked bradycardia and sinus arrhythmia 60 seconds after injection of 1.0 U/kg of vasopressin. The sinus arrhythmia was usually accompanied by different degrees of the sinus bradycardia. In 17 of 24 rabbits tested, the reduction of cardiac rate was more than 50% of initial rate at 2 minutes after injection. In an extreme case, the cardiac rate reduced to 20% of the initial rate. Recovery to approximately 80% of the initial rate was attained 20 minutes later in 9 of 24 rabbits. In the other rabbits, recovery was about 60% of the initial rate.
Atrioventricular conduction
The PQ interval was variably affected by administration of 1.0 U/kg : slight pro longation in 6, slight shortening in 4 and no significant changes in 14 of 24 rabbits. Generally, the prolongation of PQ interval was associated with a high degree of sinus bradycardia or a disturbance of atrioventricular conduction, while the shortening was seen with an atrioventricular extrasystole. Extrasystole occurred in 14 of 24 rabbits. Nine of them were ventricular and the remaining 5 were intermingled with the supraventricular one. The ECG in a half of animals which suffered from the extra systole showed a prolongation or shortening in PQ interval. The frequency, latency and duration of manifestation of the extrasystole varied individually. Numbers of mani festation of the extrasystole during the vasopressin action were less than five in 8 rabbits and more than five in 6 rabbits.
Ventricular changes of ECG
The intravenous injection of 1.0 U/kg of vasopressin produced an elevation of ST level, an increase in height of T wave, a depression of ST level and a flattening of T wave. The frequency of occurrence was in order of the above description .
The increase in height of T wave was observed in 21 of 24 rabbits (88%) . In 17 of 21 rabbits, this occurred simultaneously with or after some delay to the sinus arrhythmia. Only in 3 rabbits, the increased T wave preceded the arrhythmia in onset. The duration of the changes in T wave also varied individually : 4 within three minutes, 13 from three to eight minutes, and 4 more than eight minutes. Intervals of more than five hours were required to obtain reproducible changes in T wave in the same rabbit.
The elevation of ST level was seen in 22 of 24 rabbits. The latency before onset was 10 to 30 seconds in 17 of 22 rabbits, and the ST elevation manifested at most within 30 seconds after the increase in height of T wave. Only in 2 rabbits, ST level elevated without the T increase. The duration of the ST elevation varied from 5 to 130 seconds, 16 of 22 being within a range of 50 to 90 seconds. The recovery to the initial ST level was usually gradual, and sometimes recurrence of the ST elevation intervened in a partial recovery. When ST depression occurred, it followed the ST elevation and usually began to appear with latencies of 1 to 3 minutes and lasted for about 3 to 5 minutes:
Uptzmat dose o f vasopresszn as coronary vasoconstrictor
Although the intravenous injection of 1.0 U/kg of vasopressin produced marked ECG changes characteristic of myocardial hypoxia without . behavioral changes other than somewhat respiratory stimulation and defecation of loose stool ,. more than five hours were required to obtain similar pattern of the , ECG changes following repeated injec tions of the dose. To determine a dose of vasopressin which produces definite but easily reproducible changes in ECG, the single injection of 0.5 and 0.25 U/kg was tested in 12 rabbits. The results are shown in Table 2 . The decrease in the dose resulted in reduced onset and degree of ECG changes. The dose of 0.5 U/kg produced the sinus arrhythmia in 10 of 12 rabbits (83%) following the latent period of 10 to 30 seconds. The duration of arrhythmia was less than 3 minutes in 6 rabbits, and the longest was approximately 7 minutes. The sinus bradycardia occurred simultaneously with or somewhat delayed to the onset of arrhythmia in 11 of 12 rabbits. In 5 of them, the decrease in rate at 2 minutes follow ing injection was nearly 50% of the initial rate. Recovery to 80% of initial rate was attained 20. minutes later in 8 rabbits. The extrasystole was observed in only one rabbit.
In another rabbit, PQ interval was slightly prolonged 40 seconds to 3 minutes after vasopressin. The extent of T increase and ST elevation following 0.5 and 0.25 U/kg was less than that following 1.0 U/kg. With decrease in the dose of vaso pressin, in general, the onset and extent of the vasopressin-induced ECG changes were reduced. In addition, nearly equal interval to that following 1.0 U/kg was required to allow sufficient time for reproducing the same type of ECG changes following successive injections. Therefore, the dose of 1.0 U/kg was adopted in order to evaluate coronary vasodilating effect of 10-methoxydeserpidine.
Reproducibility of ECG changes followings repeated injections of vasopressin
Stable recording of ECG and, consequently, consistent ECG changes. following vaso-: pressin were 'obtained in fully calmed animals. The reproducibility of the ECG response to the repeated injections of vasopressin at various time-intervals was tested in the same animals. Three to five hours after a first injection of 1.0 U/kg of vasopressin, the heart rate of 2 rabbits returned to nearly original, and 6 rabbits maintained a 10% decrease and remaining 4 rabbits showed a 10% increase. But in all these animals, the T and ST changes were completely re covered. A second injection of the same dose level of vasopressin, then, produced the sinus arrhythmia in 10 of 12 rabbits (83%). The latency and duration of the arrhythmia, and onset of the ventricular extrasystole did not significantly differ from those following the first injection. Further, there was no significant difference between patterns of T wave and ST level following the first and second injections of vasopressin. Thus, a repetition of the injection of 1.0 U/kg of vasopressin at intervals of more than 5 hours within a day was able to re produce practically same response in ECG. A third injection of the same dose of vasopressin in the same interval produced the sinus arrhythmia in a similar manner to the first and second injections. However, in 3 of 4 rabbits the bradycardia was of high degree, and a recovery was never obtained within 20 minutes. On the other hand, the changes in T wave and ST level following the third injection were less in extent and shorter in duration than those following the first or second injection.
When the animal was given a daily dose of 1.0 U/kg of vasopressin in successive days, the ECG changes became, though qualitatively similar, less prominent at and after the third day. It was probably due to diarrhea with subsequent emaciation. There fore, each animal was employed for experiments only once, or twice a day at intervals of more than 5 hours, and at least 3 days were allowed before subsequent use. Accord ing to this schedule, all animals were tested on the ECG response to vasopressin prior to the evaluation of the effect of drugs described below. Thus, total number of controls amounted to ninety-five.
II Effects of atropinization on the ECG changes following vasopressin
Atropinization of the animal with a dose of 2.0 mg/kg produced tachycardia only in a slight degree from 2 minutes after injection. However, it modified the vasopressin effect on ECG (Table 3) .
The occurrence and duration of the sinus arrhythmia markedly reduced. The arrhythmia was encountered only in 50% of animals tested. The sinus bradycardia was also significantly reduced in onset, degree and duration. In addition, the occurrence of ventricular extrasystole was almost completely prevented by atropinization. On the other hand, the changes of T and ST were obtained as usual following vasopressin in atropinized rabbits (Fig. 3) . Table 4 . serpidine. The ST elevation following vasopressin was also markedly depressed and sometimes completely abolished. The ST depression or the flattening of T wave, sometimes followed the T increase or ST elevation, was almost completely abolished. These protective effects of 10-methoxydeserpidine against the vasopressin-induced ECG changes were more marked at 5 or 6-hour interval than at 1 or 2-hour interval.
IV. Effects of Persantin on the ECG changes following vasopressin
The intravenous injection of Persantin in doses of 0.2 to 5.0 mg/kg did not produce significant changes in behavior and ECG rhythm and patterns. Two to five minutes after the doses of Persantin, the intravenous injection of 1.0 U/kg of vasopressin produced the ECG changes similar to those observed without Persantin. Only ventricular extra systole was significantly reduced in frequency. The results are shown in Table 5 . The Unexpected failure of Persantin to prevent the action of vasopressin on ECG might have been due to the hypotensive effects of Persantin. Consequently, Persantin was administered by continuous infusion of a rate of 0.02 mg/kg/min for 10 minutes without markedly affecting systemic blood pressure. Vasopressin was injected 5 minutes after start of the infusion. Although the T increase was produced by vasopressin, the dura tion was significantly shortened.
In addition, the ST elevation and depression were reduced in onset and extent, and the T flattening was prevented in onset.
DISCUSSION
Relative importance of several determinants of coronary blood flow remains un settled. Toda et al. (5) have reported a similarity of the temperature rise of the ear skin following administration of 10-methoxydeserpidine and amyl nitrite in unanesthetized but restrained rabbits. The skin temperature rise was markedly depressed by anesthesia or surgical procedure. It is possible that the increase in regional blood flow results in a rise of the ear temperature, and that such changes occur only in unanesthetized animals under a minor affection by external stimuli. Therefore, the effects of 10 methoxydeserpidine on the action of vasopressin on ECG were tested in unanesthetized but restrained rabbits.
Intravenous injection of vasopressin produced a variety of EGG changes : sinus bradycardia, sinus arrhythmia, prolongation of PQ interval, supraventricular or ventri cular extrasystole, increase in height of T wave, elevation or depression of ST level and flattening of T wave. These ECG changes consistently appeared when given more than 0.5 U/kg of vasopressin. The repetition of the injection of 1.0 U/kg of vasopressin twice a day at intervals of more than 3 days reproduced almost same pattern of the ECG changes each time. Atropinization of the animal markedly reduced the mani festation and duration of sinus arrhythmia and sinus bradycardia following -1.0 U/kg of vasopressin. In addition, atropine almost completely blocked' Tire manifestation of ventricular or supraventricular extrasystole. The depression of 'the ventricular extra systole following atropinization is incompatible with the report of Hecht-and Nadel ' (8) that atropine exerts negligible effect on the vasopressin-induced extrasystole. On the other hand, the changes in T wave and ST level were hardly affected by atrop'iniza tion. Therefore, it is likely that the ventricular extrasystole, sinus arrhythmia and sinus bradycardia are, at least in part, related to cholinergic reflex mechanism. The changes in T wave and ST level, on the other hand, might be due to the hypoxia of the heart resulted from the coronary vasoconstriction following vasopressin. Tardos and Leszkovszky (10) assayed the coronary vasodilating activity of reserpine in rats, using the changes in T and ST following vasopressin as criteria for coronary vasocon striction. They demonstrated that reserpinization increased the ED50 value of vaso pressin to evoke the changes in T and ST.
In the present experiment the pretreatment with 10 mg/kg of 10-methoxydeserpidine reduced the manifestation of ventricular extrasystole, despite the increased evoking of sinus arrhythmia and sinus bradycardia. In addition, the pretreatment with the drug reduced the extent of the T increase and the occurrence of the ST elevation following vasopressin. The ST depression and the T flattening, sometimes followed the T increase and ST elevation, were also annuled. These effects of 10-methoxydeserpidine on 'the ECG changes following vasopressin were more marked at 5 or 6-hour interval than at I or 2-hour interval. Although whether catecholamine depletion in the coronary vessel is related to the preventive effect of 10-methoxydeserpidine against vasopressin was not determined in the present experiment, the time course of the preventive action of l0-methoxydeserpidine coincided well with the course of the skin temperature rise of the rabbit ear shown by Toda et al. (5) .
The coronary vasodilating action of Persantin was confirmed by several investigators (11) (12) (13) (14) using the direct measuring method of coronary flow. However, in the present method the intravenous injection of 0.2 to 5.0 mg/kg Persantin was ineffective on the EGG changes due to vasopressin. Mosher et al. (15) demonstrated that coronary blood flow is dependent not only on coronary vascular resistance and cardiac rate but also on perfusion pressure. Since the blood pressure fall reaches its lowest level 3 to 5 minutes after Persantin and the rise to the original level is very slow (11), the decreased perfusion pressure might have masked the coronary vasodilating action of Persantin injected 2 to 5 minutes prior to vasopressin. The assumption was confirmed by the finding that the intravenous infusion of a rate of 0.02 mg/kg/min of Persantin for 10 minutes, if slightly, depressed the onset and extent of the T and ST changes following vasopressin.
SUMMARY
The effects of 10-methoxydeserpidine on the ECG changes produced by vasopressin (LO U/kg, i.v.) were studied in unanesthetized but restrained rabbits. 10-Methoxydeserpidine reduced the occurrence of ventricular extrasystole but pro moted the manifestation of sinus arrhythmia and sinus bradycardia.
The increase in height of T wave and the elevation of ST level following vasopressin were markedly reduced in occurrence and extent. The ST depression and the flattening of T wave, sometimes followed the ST elevation and the T increase, were abolished.
